Europe can achieve herd immunity by July: EU commissioner

The note of optimism comes even as several European countries have started reimposing restrictions as they contend with surging coronavirus infections, and after mixed messaging on the safety of a key jab.

AFP
March 22, 2021 / 12:00 PM IST

Source: AP

Europe could have herd immunity against COVID-19 by July, a European Union commissioner has said, as incoming jabs are expected to speed up the continent's sluggish vaccine rollout.

The note of optimism comes even as several European countries have started reimposing restrictions as they contend with surging coronavirus infections, and after mixed messaging on the safety of a key jab.

"Let's take a symbolic date: by July 14, we have the possibility of achieving immunity across the continent," Thierry Breton, the EU's commissioner for the internal market told French broadcaster TF1.

"We're in the home stretch, because we know that to beat this pandemic there's just one solution: vaccination. The vaccines are arriving," he said.

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

More than a third of France's population is now under renewed lockdown, while frustrations over virus curbs spilled into weekend demonstrations in Germany, Amsterdam, Bulgaria and Switzerland.

Europe's battle to prevent a deadly third wave of infections has been complicated by a patchy vaccine drive that included several nations temporarily halting AstraZeneca's shots in response to isolated cases of blood clots.

Most have since resumed using the vaccine after the European Medicines Agency found it "safe and effective".

But AstraZeneca has delivered only 30 percent of the 90 million doses it promised the EU for the first quarter.

Breton said he was confident more vaccines will arrive soon, with 300-350 million doses expected between March and June.

He added that 55 factories would now be producing vaccines in Europe.

Follow our full coverage of the coronavirus pandemic here.
AFP
TAGS: #coronavirus #Europe #Herd Immunity #World News
first published: Mar 22, 2021 11:57 am